Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5607-5621
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5607
Table 2 Characteristics of patients stratified according to recurrence status
ParameterRecurrenceNo recurrenceP value
(n = 76)(n = 96)
Sex, male/female63/1376/200.537
Age, yr54.6 ± 10.352.7 ± 10.60.231
Etiology, yes/no
HBV51/2570/260.407
Cirrhosis23/5336/600.321
Ascites11/656/900.073
Laboratory results in U/L
ALT49 (11-1315)39 (7-1436)0.291
AST50 (16-1075)40 (11-1493)0.308
ALP111 (30-732)89 (36-867)0.149
GGT80 (12-623)62 (14-914)0.084
PLT as 109/L136 (41-370)117 (3-486)0.055
PT (INR)1.06 (0.82-1.63)1.06 (0.73-1.62)0.697
AFP, ≥ 200/< 200 ng/mL38/3236/500.122
Tumor
Size, ≥ 5/< 5 cm57/1937/59< 0.001
Type, multiple/single18/5814/820.128
Vascular invasion, yes/no8/686/900.308
Noninvasive model score
CLIP1 (0-4)1 (0-4)0.027
Pohl, negative/positive47/3960/360.930
AARP, negative/positive14/6211/850.198
AAR1.08 (0.13-3.29)1.02 (0.09-4.85)0.826
API7 (1-10)7 (2-10)0.319
CDS6 (2-9)6 (3-9)0.286
APRI0.90 (0.16-19.71)0.90 (0.17-55.71)0.658
FIB-42.90 (0.51-17.98)2.94 (0.40-81.57)0.384
FibroQ4.68 (0.48-22.82)4.49 (0.14-108.25)0.224
Lok index0.56 ± 0.230.58 ± 0.220.600
GUCI1.04 (0.14-19.32)0.95 (0.17-83.56)0.624
APGA22.95 (6.03-89.35)19.03 (5.81-92.94)0.136
PAPAS3.67 (1.52-9.40)3.02 (1.67-5.75)0.136
Survival in mo23 (5-120)87 (1-117)0.003
Death, yes/no69/718/78< 0.001